Skip to content

To evaluate the Safety and efficacy of Unani formulation in the treatment of Palpitation

Clinical Validation of Unani Pharmacopoeial Formulation â?? Dawa-ul-Misk Mutadil Sada in Khafaqan (Palpitation)

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/02/005525
Enrollment
300
Registered
2015-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Khafaqan (Palpitation) Health Condition 2: R002- Palpitations

Interventions

Intervention1: Dawa-ul-Misk Motadil Sada: Dawa-ul-Misk Motadil Sada, 5 gm, orally twice daily with water after meals for a period of 4 weeks Control Intervention1: nil: na

Sponsors

Central Council for Research in Unani MedicineCCRUM
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Patients of either sex in the age group of 18-60 • Patients of Palpitation (heart rate: 100 bpm) with and without any of the following symptoms/ signs: ï?§ Ghabrahat ï?§ Feeling of Missed Beat ï?§ Discomfort in Chest ï?§ Sweating ï?§ Dizziness

Exclusion criteria

Exclusion criteria: • History of any heart diseases • History of hepatic, renal disorders, diabetes mellitus, hypertension, anaemia, COPD • History of thyroid dysfunction • History of hypersensitivity to any ingredient of the study drug. • Participants with history of long term use of any other drugs such as anti-epileptic, anti-arrhythmic and anti-psychotic drugs etc. • History of Addiction (smoking, alcohol, drugs) • Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Improvement in signs and symptomsTimepoint: 4 weeks

Secondary

MeasureTime frame
Hematological and biochemical assessments for safetyTimepoint: 4 weeks

Countries

India

Contacts

Public ContactDR PRADEEP KUMAR

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@gmail.com9810161758

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026